how to get on glp 1 for pcos Navigating PCOS: GLP-1 Medicines Are Changing the Game – Trim GLP-1 medications are getting attention

These medications (including semaglutide, dulaglutide, and liraglutide) are typically considered when: Metformin and other oral medications have not achieved adequate glycaemic control The patient has a BMI 35 kg/m (or lower thresholds, typically by around 2.5 kg/m, for people of certain ethnic backgrounds including South Asian) Weight loss would benefit other obesity-related comorbidities Insulin therapy is being considered but would have significant occupational implications or weight gain is a concern Continuation criteria apply: for example, treatment should reduce HbA1c by at least 11 mmol/mol (1.0%) and weight by at least 3% at 6 months to be continued

The Department of Health and Human Services recommend strength training at least two days per week

Moreover, GLP-1R has not yet been identified on human myocardial cells, negating any direct effects of GLP-1RAs on myocardial cells

Collectively, these threshold-attaining and multidimensionally consistent signals provide a foundation for translating biomarker improvements into clinically perceptible benefits in specific populations